AR084446A1 - Derivados de bifenilo y su uso en el tratamiento de enfermedades de la piel y de la cavidad bucal - Google Patents

Derivados de bifenilo y su uso en el tratamiento de enfermedades de la piel y de la cavidad bucal

Info

Publication number
AR084446A1
AR084446A1 ARP110104831A ARP110104831A AR084446A1 AR 084446 A1 AR084446 A1 AR 084446A1 AR P110104831 A ARP110104831 A AR P110104831A AR P110104831 A ARP110104831 A AR P110104831A AR 084446 A1 AR084446 A1 AR 084446A1
Authority
AR
Argentina
Prior art keywords
bifenyl
derivatives
treatment
oral cavity
skin diseases
Prior art date
Application number
ARP110104831A
Other languages
English (en)
Inventor
Ravi Subramanyam
Guofeng Xu
Jennifer Gronlund
Shamim Ansari
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR084446A1 publication Critical patent/AR084446A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24Halogenated derivatives
    • C07C39/373Halogenated derivatives with all hydroxy groups on non-condensed rings and with unsaturation outside the aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compuestos de fórmula (1) o una sal de los mismos; en donde: R1 y R5 se seleccionan cada uno en forma independiente del grupo H, OH y alcoxi; R2 - R4 y R6 - R8 se seleccionan cada uno en forma independiente del grupo H, OH, F, Cl, Br e I; R9 y R10 se seleccionan cada uno en forma independiente del grupo H, alquilo, alquenilo, alquinilo y arilo; siempre y cuando: al menos uno de los grupos R1 y R5 es OH o alcoxi; y al menos uno de los grupos R2 - R4 y R6 - R8 es F, Cl, Br o I; composiciones que contienen dichos compuestos; y métodos para la elaboración y su uso.
ARP110104831A 2010-12-21 2011-12-20 Derivados de bifenilo y su uso en el tratamiento de enfermedades de la piel y de la cavidad bucal AR084446A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2010/061428 WO2012087289A1 (en) 2010-12-21 2010-12-21 Halogenated biphenols as antibacterial agents

Publications (1)

Publication Number Publication Date
AR084446A1 true AR084446A1 (es) 2013-05-15

Family

ID=44484849

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110104831A AR084446A1 (es) 2010-12-21 2011-12-20 Derivados de bifenilo y su uso en el tratamiento de enfermedades de la piel y de la cavidad bucal

Country Status (14)

Country Link
US (1) US9334212B2 (es)
EP (1) EP2655304B1 (es)
JP (1) JP5676014B2 (es)
CN (1) CN103261138B (es)
AR (1) AR084446A1 (es)
AU (1) AU2010365812B2 (es)
BR (1) BR112013015973B1 (es)
CA (1) CA2822027C (es)
MX (1) MX344516B (es)
RU (1) RU2549543C2 (es)
SG (1) SG190880A1 (es)
TW (2) TW201520194A (es)
WO (1) WO2012087289A1 (es)
ZA (1) ZA201304255B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6336870B2 (ja) * 2013-09-30 2018-06-06 日本ポリプロ株式会社 ビフェノール化合物及びそれを用いるオレフィン重合用触媒並びにオレフィン重合体の製造方法
US11802258B2 (en) * 2017-09-25 2023-10-31 Takasago International Corporation Perfume precursor
CN110615742B (zh) * 2019-09-20 2021-11-19 广东省禾基生物科技有限公司 厚朴酚衍生物及其制备方法与应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3720721A (en) 1970-07-09 1973-03-13 Gen Electric Halogenated biphenols and methods for preparing the same
US3956403A (en) 1971-08-05 1976-05-11 General Electric Company Brominated biphenols
DD131746A1 (de) * 1976-03-15 1978-07-19 Axel Kramer Verfahren zur herstellung antimikrobiell wirksamer,epidermal vertraeglicher verbindungen aus abfaellen der 4-chlor-2-methylphenol-synthese
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
DK0382213T3 (da) * 1989-02-08 1995-07-10 Otsuka Pharma Co Ltd Biphenylderivat, middel til reparation af eller beskyttelse mod nervecelledegeneration og fremgangsmåde til fremstilling af et phenylderivat, som indgår i dette middel
WO1997020878A1 (fr) 1995-12-04 1997-06-12 Idemitsu Kosan Co., Ltd. Resine de polycarbonate, resine de polycarbonate reticulee et photorecepteur electrophotographique
JPH09278638A (ja) * 1996-04-17 1997-10-28 Kanebo Ltd 腋臭治療および予防剤
US6500409B1 (en) * 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
US7435837B2 (en) 2003-10-24 2008-10-14 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
JP2008523226A (ja) 2004-12-17 2008-07-03 ザ プロクター アンド ギャンブル カンパニー 改良された疎水性汚れ洗浄のための親水性変性ポリオール
US8425881B2 (en) * 2005-03-18 2013-04-23 Colgate-Palmolive Company Antibacterial 3′,5-disubstituted 2,4′-dihydroxybiphenyl compounds, derivatives and related methods
GT200600159A (es) 2005-04-22 2007-03-14 Derivados benzodioxano y benzodioxolano y usos de los mismos
CN101203505A (zh) 2005-04-22 2008-06-18 惠氏公司 苯并二氢吡喃和苯并吡喃衍生物及其用途
US20070041914A1 (en) * 2005-08-17 2007-02-22 Colgate-Palmolive Company Inhibition of bacterial deposition on oral surfaces
CN101296684B (zh) 2005-08-25 2012-10-10 高露洁-棕榄公司 保湿组合物
GB0722680D0 (en) * 2007-11-19 2007-12-27 Topotarget As Therapeutic compounds and their use
TWI459957B (zh) 2010-02-24 2014-11-11 Colgate Palmolive Co 口腔保健組成物
TWI422382B (zh) 2010-02-24 2014-01-11 Colgate Palmolive Co 加強木蘭活性物之溶解度及傳送的組成物
SG183120A1 (en) 2010-02-25 2012-09-27 Colgate Palmolive Co Synthesis of magnolol and its analogue compounds
MY161382A (en) 2010-07-29 2017-04-14 Colgate Palmolive Co Phosphate free oral care compositions based on magnolia antibacterial agent

Also Published As

Publication number Publication date
CN103261138A (zh) 2013-08-21
WO2012087289A1 (en) 2012-06-28
MX2013007249A (es) 2013-08-01
SG190880A1 (en) 2013-07-31
RU2549543C2 (ru) 2015-04-27
RU2013134170A (ru) 2015-01-27
EP2655304A1 (en) 2013-10-30
JP2014510703A (ja) 2014-05-01
US9334212B2 (en) 2016-05-10
BR112013015973A2 (pt) 2018-07-10
EP2655304B1 (en) 2017-12-06
JP5676014B2 (ja) 2015-02-25
TW201302692A (zh) 2013-01-16
BR112013015973B1 (pt) 2018-12-11
AU2010365812B2 (en) 2014-12-18
CA2822027A1 (en) 2012-06-28
CN103261138B (zh) 2015-08-12
ZA201304255B (en) 2018-12-19
MX344516B (es) 2016-12-19
CA2822027C (en) 2016-05-31
TW201520194A (zh) 2015-06-01
AU2010365812A1 (en) 2013-05-02
US20130280185A1 (en) 2013-10-24

Similar Documents

Publication Publication Date Title
AR087668A1 (es) Derivados de oxazina y su uso en el tratamiento de enfermedades
DOP2014000133A (es) Triazolopiridinas sustituidas
NI201800033A (es) Derivados de 8-[6-[3-(amino)propoxi]-3piridil]-1-isopropil-imidazo[4, 5-c]quinolin -2-ona como moduladores selectivos de la cinasa de la ataxia telangiectasia mutada (atm) para el tratamiento del cáncer.
AR085004A1 (es) Inhibidores selectivos de glicosidasas y usos de los mismos
BR112013025881A2 (pt) composto representado pela fórmula geral (i), composto ou um sal do mesmo, inibidor deagregação tau, inibidor de b-secretase, inibidor de agregação de b-proteína amiloide, composição farmacêutica, preparação oral ou parenteral e composto representado pela fórmula geral (ii)
CO6321276A2 (es) Derivados de tiazol usados como inhibidores de pi3- cinasa
PE20210667A1 (es) Derivados de benzamida para la inhibicion de la actividad abl1, abl2 y bcr-abl1
AR081058A1 (es) Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer.
DOP2012000310A (es) Morfolinopirimidinas y su uso en terapia
UY32096A (es) Derivados de 2-carboxamida - cicloamino - urea especìficos, sus sales farmacèuticamente aceptables, composiciones contenièndolos, pro-farmacos de los mismos, procesos para su produciòn y aplicaciones
CL2012001391A1 (es) Compuestos derivados de triazolopiridina sustituidos, inhibidores de la quinasa mps-1; composición farmacéutica; procedimiento de preparacion; combinación farmacéutica y uso para la profilaxis o tratamiento de una enfermedad hiperproliferativa tal como tumores hematológicos, sólidos y/o sus metástasis; compuestos intermediarios.
CL2013001947A1 (es) Composicion farmaceutica que comprende pioglitazona; uso de pioglitazona para tratar alzheimer; composicion que comprende pioglitazona.
UY33961A (es) Compuestos de bis(fuoroalquil)-1,4-benziodiazepinona
CY1116439T1 (el) Τριαζολοπυριδινες
ECSP13012596A (es) Proceso de elaboración para derivados de pirimidina
CY1120378T1 (el) Υποκατεστημενα παραγωγα του διφαινυλο βουτανοϊκου φωσφονικου οξεος ως αναστολεις νερ (ουδετερης ενδοπεπτιδασης)
DOP2014000216A (es) Nuevos derivados de tienopirimidina en particular como agentes anticancerosos mediante la inhibición de la alk quinasa, procesos para su preparación y sus usos terapéuticos
AR077080A1 (es) Compuestos de 2,3-dihidro-1h-indeno
UY32153A (es) Inhibidores de piridomidinona de pi13ka(alfa) y mtor
BR112012029647A2 (pt) novos derivados de pirimidinas
ECSP12012338A (es) Triazolopiridinas sustituidas
AR078278A1 (es) Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro.
BRPI0906444B8 (pt) compostos de 4-piridinona, composição farmacêutica que os compreende, bem como uso dos mesmos
BR112014029439A2 (pt) derivados de ácido salicílico, sal farmaceuticamente aceitável dos mesmos, composição dos mesmos e método de uso dos mesmos
UY32748A (es) 2-carboxamida-cicloamino-ureas

Legal Events

Date Code Title Description
FB Suspension of granting procedure